Univariate survival analysis demonstrated CXCL1 expression in CAFs, tumor size and lymph node metastasis were significantly associated with overall survival of ESCC patients treated with chemoradiotherapy (Table 2). The gene discussed is CXCL1; the disease is metastatic malignant neoplasm in the lymph nodes.